IRBT continues to maintain its strong balance sheet, which includes zero long term debt , while growing revenues with a shift to home robotics to more than make up for the current decline in the defense robot sales. With new areas of growth on tap: FDA certification of their medical robot, and new pool and gutter cleaning robots, IRBT is way under valued and relatively close to its 52 week lows. This is the time to buy and hold as it will eclips all time highs as the orders start to pile in and more information comes out with the Raytheon partnership!
Sentiment: Strong Buy